Studies on the structural basis of antibody affinity maturation have been carried out by measuring the affinity of secreted antibodies, and information on structures has often been obtained from nucleotide sequences of BCRs of memory B cells. We considered it important to establish whether the repertoire of secreted antibodies from plasma cells is really in accord with that of BCRs on memory B cells at the same time points post-immunization. We isolated plasma cells secreting antibodies specific to (4-hydroxy-3-nitrophenyl)acetyl (NP) hapten by affinity matrix technology using biotin-anti-CD138 and streptavidin-NP-allophycocyanin, to which anti-NP antibodies secreted by autologous plasma cells bound preferentially. We found that plasmablasts occupied >90% of the antibody-secreting cell compartment in the primary response and that they secreted antibodies whose V H regions were encoded by V186.2 + Tyr95 + sequences, which provided an increase in the medium level of affinity by somatic hypermutation (SHM) of heavy chains at position 33. After secondary immunization, a further increase in antibody affinity was observed, which was explained by the appearance of a number of plasma cells secreting V186. 
Introduction
The immune response of C57BL/6 mice to a hapten, (4-hydroxy-3-nitrophenyl)acetyl (NP), has been widely employed in the analysis of affinity maturation since anti-NP antibodies have unique structural properties; they are encoded by the canonical gene segments, V186.2, DFL16.2 and JH2 for the heavy chain and Vλ1 and Jλ1 for the light chain (1) although V H genes analogous to V186.2 have also been employed (2) . Therefore, anti-NP antibodies are rather homogeneous in terms of usage of their gene segments. However, even though they are encoded by canonical genes, these antibodies are heterogeneous in sequences of their complementarity-determining regions (CDRs), especially in the third CDR of heavy chains (CDRH3), due to the addition of an N-region by terminal deoxyribonucleotidyl transferase, which adds nongermline-encoded nucleotides during immunoglobulin gene rearrangement (3) . By preparing hybridomas, we previously demonstrated two distinct anti-NP antibody populations that were characterized by the amino acid residue at position 95 [Kabat numbering (4) ). This antibody appeared at the early stage of immunization, and its affinity increased ~10-fold with the introduction of an amino acid replacement of Trp33 with Leu (Leu33 + ) by means of somatic hypermutation (SHM) (5, 6) . The other was also encoded by V186.2 but harbored Gly95 (V186.2 + Gly95 + ) instead of Tyr95. Since Gly95 appeared on pairing with His100, we referred to this antibody having both Gly95 and His100 as Gly95 + , and it had gained ~100-fold higher affinity than that of V186.2 + Tyr95 +
Leu33
+ antibodies because of the induction of multiple SHMs in both heavy and light chains. Although the affinities of germline antibodies were similar, the maximum affinity attainable by SHM was different between V186.2 + Tyr95 + and V186.2 + Gly95 + antibodies, reflecting the difference in their ability to raise affinity by SHM (7) . Although affinity maturation of anti-NP antibodies has been studied extensively by focusing on V186.2 + Tyr95
+ antibodies, it is necessary to take into account antibodies encoded by V186.2 +
Gly95
+ genes since B1-8 (V186.2 + Tyr95 + ) knock-in mice lacking these antibodies failed to show the maturation phenomenon (8) .
Previously, we followed changes in the affinity of memory BCRs using a chromophore protein, allophycocyanin (APC), which was conjugated with varying numbers of NP, and results showed that V186. 
+ cells required a longer period to attain a high affinity (9, 10) . Since the affinities of secreted antibodies in blood were shown to increase after secondary immunization, it was necessary to examine which antibodies are involved in anti-NP antibody affinity maturation for a complete understanding of this phenomenon. This was carried out by analyzing antibody-secreting cells (ASCs), which consist of plasmablasts and plasma cells that have differentiated from such B cells as germinal center (GC) B cells and memory B cells. The former was considered to be a precursor of the latter in occupation of the final differentiation stage of B lineage cells (11) . However, since it is not yet known whether the antibody repertoire of plasmablasts is identical to that of plasma cells, it is necessary to isolate the respective cell compartments and analyze V H nucleotide sequences. For isolation of plasma cells, the cellular affinity matrix approach has been used. With this method, cells are first coated with capture antibodies that recognize molecules secreted from autologous cells, and they are then captured by second antibody reagents so that the secreting cells can be detected by flow cytometry (12, 13) . We modified this technique for isolation of plasma cells secreting NP-specific antibodies by labeling cells using a complex of biotin-anti-CD138 and streptavidin-NP-APC (NP-APC avi ) to which anti-NP antibodies secreted from parent plasma cells were trapped (14) .
In the present experiments, the process of antibody affinity maturation was tracked by measuring the binding ratio of NP 2 -BSA to NP 26 Murakami et al. (15) , we discuss here the relationship between plasmablasts and plasma cells that appeared after secondary immunization with respect to plasma cell ontogeny. We also suggest that secondary immunization is necessary for inducing differentiation of silent memory B cells that have gained higher affinity as plasma cells over the course of the vaccination schedule.
Methods

NP-protein conjugates and anti-NP antibodies
NP-protein conjugates were prepared as described previously (16) . Briefly, the hydroxysuccinimide ester of NP (NP-OSu) was coupled to carrier proteins such as chicken γ-globulin (CGG), BSA, APC and streptavidin-APC (APC avi ) by incubation in 0.1 M sodium bicarbonate buffer (pH 8.5) containing 0.15 M NaCl for 1 h at room temperature. Any excess reagents or byproducts of the reaction were removed by passing the mixture through a Sephadex G-25 column (Amersham Biosciences) or performing dialysis against PBS. The average molar ratio of NP per carrier protein was calculated by measuring OD at 280 and 430 nm except in the case of NP-APC or NP-APC avi . The number of NPs per APC or APC avi was approximated based on the molar ratio of NP-OSu and APC or APC avi in the reaction mixture and expressed as NP lo , NP med and NP hi , respectively. Hybridomas producing the anti-NP antibodies, B2 and E11 were prepared as described previously (16) . N1G9 was provided by Prof. K. Rajewsky. The equilibrium association constants (K a ) of N1G9, B2 and E11 to NP-ε-aminocaproic acid, as determined by isothermal titration calorimetry, are 2. , respectively (6, 7).
Immunization
The experiments using mice were carried out in strict accordance with recommendations in the Guide for the Care and Use of Laboratory Animals of Tokyo University of Science. The protocol was approved by the Committee on the Ethics of Animal Experiments of Tokyo University of Science (Permit Number: S13017). All efforts were made to minimize suffering. Female C57BL/6 mice (Crea) at 6-10 weeks of age were immunized i.p. with 100 µg NP 40 -CGG adsorbed onto 100 µl of alum gel. For analysis of the memory response, mice received a secondary i.p. immunization with 100 µg NP 40 -CGG in PBS at 7 weeks after the primary immunization.
Spleens were excised at various time points and single-cell suspensions were prepared. In some experiments, bone marrow was aspirated from both femurs.
Transfectants
A mouse B-cell lymphoma, K46 and a plasmacytoma, SP2/0, were used for preparing B-cell transfectants expressing NP-specific BCRs and secreting anti-NP antibodies, respectively. The membrane-form immunoglobulin (mIg) μ chain gene was amplified by PCR from cDNA of BALB/c mouse spleen cells using the primers: CH-XhoI-F1, 5′-agtctcgagtgagagtcagtccttc-3′ and IgMm-R1, 5′ taatggcccagccggcctcatttcaccttgaacaggg-3′. V(D)J genes of N1G9, B2 and E11 were obtained by PCR using cDNA from the respective hybridomas and primers: Bud Hs, 5′-aggcggccgcacacaggacctcaccatg-3′ and VH-XhoI, 5′-ttactcgagctgtgagagtggtgcctt-3′. The Cμ gene was cloned into pCR2.1-TOPO vector, followed by ligation with V(D)J genes. The complete anti-NP mIgμ gene was cloned into pBudCE4.1 vector (Invitrogen). The λ1 chain gene was amplified from cDNA of N1G9, B2 and E11, using primers: BudEF-NotI-F, 5′-aggcggccgcttagacctggtttgtgaattatg-3′ and EFLa, 5′-aggcggccgcaggttagatgacctaggaac-3′, and cloned into pBudCE 4.1 vector. These were digested with FspI for linearization and transfected into K46 cells using an electroporator Gene Pulser Cuvettes (BIO-RAD). The transfectants were selected in the presence of 0.4 mg ml −1 Zeocin. The SP2/0 plasmacytoma secreting anti-NP antibodies, N1G9, B2 and E11 were prepared by transfecting the respective H-chain genes of secreted-form Ig (sIg) and l-chain genes. In some experiments, SP2/0 cells transfected with cyan fluorescence protein (CFP) were used.
Flow cytometry
Cells were stained on ice for 15 min in a FACS washing solution (PBS + 1% BSA) at 5 × 10 6 ml −1 with biotin-or fluorophoreconjugated antibodies. The mean fluorescence intensity of the cells was recorded using a FACSCanto II (BD Biosciences). Antibodies used for flow cytometry were anti-mouse IgM (PerCP-Cy5.5-II/41), anti-mouse IgG1 (PE-A85-1), FITC/ PE-labeled rat anti-mouse λ chain (Igλ), anti-CD45R/B220 (PE-Cy7-RA3-6B2), biotin-anti-CD138/syndecan (281.2) and PE-streptavidin. The data were analyzed using FlowJo software (Tree Star).
cDNA synthesis and sequencing
Cells were sorted using a FACSAriaII (BD Biosciences). Individual cells were sorted into 5 µl of an oligo(dT)-primed cDNA reaction mixture containing murine leukemia virus reverse transcriptase with the recommended reverse transcriptase buffer, 0.5 nM spermidine, 100 µg ml −1 BSA, 10 ng µl −1 oligo(dT), 200 µM each dNTP, 1 mM dithiothreitol, 200 U ml −1 RNAsin and 100 µg ml −1 Escherichia coli tRNA, in 96-well microtiter plates. Reaction mixtures were incubated at 37°C for 90 min and stored at −80°C until analysis was performed. Twenty-five microliters of reaction mixtures containing 2 µl of cDNA from individual single-cell cDNA preparations were set up using the following reagents: 2 U ml −1 Taq polymerase with the recommended 1× reaction buffer, 0.1 mM of each dNTP and varying concentrations of primers and MgCl 2 . The first PCR was performed for 35 cycles.
Results
Affinity maturation of anti-NP IgG antibodies
Antigens harboring a different number of hapten groups per carrier protein, such as NP-BSA, are widely employed in estimating the relative affinity. Figure 1(A) shows the binding of control antibodies to NP 2 -and NP 26 -BSA. Our antibodies bound to NP 26 -BSA irrespective of affinity, while the binding to NP 2 -BSA was affinity dependent. Therefore, the ratio of binding to NP 2 -BSA versus NP 26 ) exhibited the highest ratio, ~1.2 (Fig. 1A) .
The changes in the amounts of IgG1 antibodies bound to NP 2 -and NP 26 -BSA as well as the NP 2 /NP 26 ratios are shown in Fig. 1 (B). Day 7 antibodies were characterized by little binding to NP 2 -BSA and provided an NP 2 /NP 26 ratio <~0.1. Antibodies capable of binding to NP 2 appeared on day 14 and their amounts increased with time. The NP 2 /NP 26 ratio reached a plateau value of ~0.7 on day 42. After secondary immunization, antibodies with higher affinities were produced, having NP 2 /NP 26 ratios of ~1. We divided the process of antibody production into three periods based on the magnitude of the NP 2 /NP 26 ratio of the secreted antibodies as indicated in Fig. 1(B) ; Phase I corresponds to early primary antibody production on day 7, Phase II, to the subsequent period of antibody production accompanied by a gradual increase in affinity between day 14 and 49 and Phase III, to the period during which antibody production is maintained after secondary immunization.
Establishment of a method for isolating plasma cells secreting anti-NP antibodies
CD138 molecules on SP2/0 cells were reacted with biotinanti-CD138, allowing for NP-streptavidin-APC (NP-APC avi ) with different NP valences (NP lo -, NP med -and NP hi -APC avi ) to be conjugated through the biotin-avidin reaction. Biotinanti-CD138/NP-APC avi labels CD138 + cells with fluorescent chromophore and, simultaneously, provides NP groups to which anti-NP antibodies secreted from autologous CD138 + cells can bind. Since the bound antibodies were detected by FITC-anti-Igλ, anti-NP ASCs were detected by flow cytometry as APC + FITC + double-positive cells. We first examined whether the anti-NP antibodies added to the medium could bind to NP-APC avi via CD138 on SP2/0 cells. All anti-NP antibodies bound to NP hi -APC avi irrespective of their affinities ( Fig. 2A) , while antibody binding to NP med -APC avi and NP lo -APC avi was affinity dependent; N1G9 failed to bind to both, while B2 bound to NP med -APC avi but not to NP lo -APC avi . Only E11 bound to NP lo -APC avi ( Fig. 2A) .
Next, we examined the binding of antibodies secreted from autologous plasma cells. In order to distinguish between BCRs (mIg) expressed on the surface and antibodies (sIg) bound to the anti-CD138/NP-APC avi complex, we Asymmetric repertoire of antibody-secreting cells 611 used anti-Igλ conjugated with different chromophores, FITC or PE. PE-anti-Igλ was added before cultivation to ensure that BCR + cells were labeled with PE. We used the following cells in our mixture; K46 (IgG2a, κ) as B cells of unknown specificity, K46 transfected with membrane-form anti-NP IgG or IgM as memory B cells with anti-NP specificity, hybridomas secreting anti-NP antibodies as plasmablasts, SP2/0-CFP as plasma cells secreting antibodies with unknown specificity (CFP genes were transfected for labeling SP2/0) and SP2/0 transfectants secreting B2 (SP2/0-B2γ) as plasma cells secreting anti-NP antibodies. After independent cultivation of these cells, antibodies secreted from SP2/0-B2γ or B2 hybridoma, which bound to biotin-anti-CD138/NP hi -APC avi , were detected with FITC-anti-Igλ (Fig. 2B) . The antibodies secreted were trapped by the biotin-anti-CD138/NP hi -APC avi complex but not by biotin-anti-CD138/NP 0 -APC avi that lacked NP.
Although only cells secreting anti-NP antibodies, B2 hybridoma and SP2/0-B2 γ were detected by FITC-anti-Igλ when experiments were carried out using independent cultures (Fig. 2B) , we observed antibody binding to all CD138 + cells when a mixture of cells was cultured, suggesting that antibodies secreted from plasma cells diffused during cultivation and bound to biotin-anti-CD138/NP hi -APC avi complexes on neighboring plasma cells (data not shown). To prevent this diffusion, we cultured cells in a medium that contained both 1% agarose and 50 ng ml −1 NP 13 -BSA. The former was expected to decrease the diffusion rate of the secreted antibodies (14) and the latter, to absorb the diffused antibodies. When the same numbers of SP2/0-CFP and SP2/0-B2γ were cultured 612 Asymmetric repertoire of antibody-secreting cells 
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with K46, K46B2μ and B2 hybridomas, ~50% of CD138 + cells were detected as an sIgλ − population, indicating that agarose and NP 13 -BSA synergistically prevented antibodies from binding to neighboring cells (Fig. 2C) . In addition, secreted antibodies were detected only on CFP − cells (SP2/0-B2γ) and not on CFP + cells (Fig. 2D) .
Isolation of ASCs from mice immunized with NP 40 -CGG
We isolated plasma cells from day 7 mice immunized with NP 40 -CGG, using biotin-anti-CD138/NP-APC avi . We then carried out detection of the bound antibodies with FITC-anti- (Fig. 3A) . Plasmablasts were also characterized as NP hi -APC-binding (NP + ) CD138
+ cells (Fig. 3B) . On the other hand, plasma cells were separated as CD138 + Igλ (FITC) + cells and were characterized by their large size, dull expression of B220 and the absence of BCR expression (Fig. 3B) , phenotypes which were consistent with those reported previously (17) (18) (19) (20) . RT-PCR analysis of cDNA revealed that mRNA encoding mIg was not expressed in plasma cells, in contrast to the significant expression of mRNA encoding sIg (Fig. 3C) − cells) synthesized only a small amount of mRNA encoding sIg (21) . (Fig. 4D) . Therefore, the ratio of plasma cells to total ASCs at these time points was <0.02. Judging from the small number of plasma cells compared to plasmablasts, the former seemed to provide a rather small contribution to 
Variation in the numbers of ASCs and B cells during immunization
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primary IgG1 antibody production. The absence of plasma cells in bone marrow on day 7 suggested that they were generated in spleen but did not migrate into bone marrow immediately. The number of plasmablasts and plasma cells in spleen had decreased to ~1/10 by day 14, suggesting that these cells were short-lived ( Fig. 4A and B) . They were further decreased by day 28 and their numbers remained the same thereafter. The decrease in these cells on day 14 was not seen in bone marrow (Fig. 4C and D) (22) . We also examined the number of plasmablasts capable of binding to NP med -APC avi (Fig. 4A  and C) . A certain fraction of NP med -APC avi -binding cells were present in spleen and bone marrow. The ratio of NP med -APC avibinding cells relative to NP hi -APC avi -binding cells (NP med /NP hi ratio) also increased with time, indicating that affinity maturation had proceeded in plasmablasts (Fig. 4E) , although the number of plasma cells was too small to allow for an accurate estimation of the NP med /NP hi ratio (data not shown). On the other hand, memory B cells exhibited a rather small change in their number compared with ASCs (Fig. 4F) . On day 42, at a time point when primary immunization had reached a steady state, there were ~4.5 × 10 3 memory B cells but only ~1.2 × 10 3 plasmablasts and ~0.1 × 10 3 plasma cells, suggesting that more memory B cells were generated compared with ASCs during Phase II. Plasma cells occupied only 6-7% of the ASC compartment, and it is not yet clear whether the antibodies have a similar repertoire to that of plasmablasts. It is also not clear whether such small numbers of plasma cells are derived from plasmablasts.
Secondary immunization on day 49 caused a remarkable increase in the cell number on day 56, especially in the number of plasma cells ( Table 1) . The ratio of cell numbers on day 56 versus day 42 was 20 in spleen and 19 in bone marrow for plasmablasts, while that of plasma cells was 91 in spleen and 19 in bone marrow. Since plasma cells were unable to proliferate in response to antigen stimulation, they may have differentiated either from memory B cells or plasmablasts, although no information was available regarding whether plasmablasts are capable of responding to antigen stimulation (23, 24) . Regardless of their origin, this selective expansion of plasma cells brought their percentage in total ASCs to 26%, much higher than the 7% seen with primary immunization on day 42, suggesting that plasma cells contributed significantly to antibody production after secondary immunization. In contrast to the rather large increase in the number of ASCs, B cells showed a small change in their number following secondary immunization (Fig. 4F) .
Frequency of SHM in antibody V H regions secreted from plasmablasts and BCRs of memory B cells with time post-immunization
We examined the frequency of SHM in antibodies secreted from plasmablasts and in BCRs of memory B cells. SHM was not observed in antibodies on day 7 but became apparent on day 14, and the average frequency increased with time (Fig. 5) . These profiles of SHM induction were similar to those of BCRs of memory B cells and GC B cells (10) . In fact, SHMs had accumulated to a similar extent in the plasmablast and memory B cell compartment on day 42. V H gene sequence analysis showed that V H regions of both memory B cells and plasmablasts were predominantly encoded by V186. Although we attempted to analyze V H gene sequences of the plasma cells, only preliminary sequence data were obtained and were insufficient for statistical analysis because of the low numbers of cells recovered (data not shown). 
Characterization of ASCs responsible for recall antibody production
Gly95
+ sequences, suggesting that the immunological memory was maintained without drastic changes in the repertoire brought on by boost immunization. Alteration in the repertoire was also not observed in antibodies secreted from plasmablasts; these antibodies were encoded by V186. 
Discussion
Comparison of the V H repertoires of plasma cells and plasmablasts or memory B cells at the same time points of immunization deepened our knowledge of the relationships between these cells in the developmental pathway as well as of the mechanism of antibody affinity maturation at the cellular level. To achieve this understanding, we first established experimental conditions for isolating plasma cells using a method based on affinity matrix technology (18) . We employed CD138 as an absolute marker of ASCs and labeled these cells using biotin-anti-CD138 and NP-APC avi . With 30-min cultivation in the presence of 50 ng ml −1 NP 13 -BSA and 1% agarose, anti-NP antibodies secreted from autologous plasma cells bound preferentially to the biotin-anti-CD138/NP-APC avi complex. Plasma cells were discriminated from plasmablasts on the basis of the expression of BCRs on the cell surface. The number of ASCs thus obtained in the present experiments was in good agreement with those reported previously (24) . We tracked antibody affinity changes using the NP 2 /NP 26 ratio as a measure of affinity, which was found to increase in a stepwise manner (Fig. 1B) . Accordingly, we divided the time course of antibody production into three periods, Phases I, II and III. Day 7 IgG antibodies had an NP 2 /NP 26 ratio of <0.1 (Fig. 1B) and were known to be encoded largely by the germline V186.2 +
Tyr95
+ sequences (17, 19) . Since antibodies having an NP 2 /NP 26 ratio of <0.1 appeared only on day 7 but not later, the ASCs responsible for their production would be short-lived. In fact, a large number of plasmablasts appeared on day 7 in spleen but their incidence declined to 1/20-1/50 by day 14. A similar decline in the number of ASCs in bone Asymmetric repertoire of antibody-secreting cells 617 marrow was not evident, suggesting that they had achieved longevity (22) . The ratio of plasma cells versus plasmablasts was ~0.07, which is in agreement with results reported by Smith et al. (17) who showed that 90% of ASCs were capable of binding to antigens. Therefore, at Phase I, only a small fraction of the ASC compartment was occupied by plasma cells. If we assume that plasmablasts are intermediates of plasma cell ontogeny, most of them seem to remain undifferentiated into the final stage of development.
The antibodies secreted from short-lived plasmablasts were substituted by those capable of binding to NP 2 (5, 6) . Simultaneous to the increase in the NP 2 /NP 26 ratio, SHMs began to accumulate in plasmablasts (Fig. 5A and B) . The NP 2 /NP 26 ratio reached a plateau value of ~0.7 on day 42, which was similar to the value of V186.2
+ antibodies such as B2 (Fig. 1A) . On day 42 when the primary immune response had reached a steady state, plasmablasts occupied 93% of the ASC compartment ( Although the NP 2 /NP 26 ratio reached a plateau on day 42, secondary immunization induced a further increase in the ratio to ~1.0 (Fig. 1B) (Fig. 6D) , and therefore contained only affinity-maturated cells. This is contrast to the plasmablast compartment that contained V186.2
+ cells that had immature affinity (Fig. 6D) . These results suggest that the affinity threshold required for differentiation of plasmablasts into plasma cells is higher than that of memory B-cell differentiation into plasmablasts. After secondary immunization, memory B cells differentiate into plasmablasts and only a portion of V186. + memory B cells that tend to differentiate into plasma cells (25) .
Memory B cells that have completed affinity maturation during primary immunization either remain memory B cells or become plasmablasts or plasma cells after secondary immunization. Since no significant difference was observed between the memory B-cell repertoire before and after secondary immunization, selective expansion of particular components did not occur on antigen stimulation, and 'memory' was preserved after proliferation. In view of the longevity of memory B cells and their limited variation in number during immunization, the role of these cells would appear to be to preserve and transmit their complete 'memory' to ASCs and daughter cells. On the other hand, the quantity and quality of antibodies in blood were regulated by a change in the numbers of plasmablasts and plasma cells which were promptly generated from the appropriate memory B cells when necessary; V186. + cells, into plasma cells. Plasmablasts and plasma cells appear to have different roles in antibody production; the former are responsible for the prompt secretion of antibodies, while the latter act to secrete antibodies with maturated affinity after secondary immunization.
In conclusion, we showed here the functional roles of memory B cells, plasmablasts and plasma cells in the immune response to NP-CGG. In particular, we showed that secondary immunization is essential for memory B cells that require a long period for affinity maturation in order to differentiate into plasma cells. Together with the dynamic changes in antibody affinities reported in other immune systems (26) (27) (28) (29) , the observations obtained from the NP hapten system used here are expected to help in understanding the immune response and to contribute to the establishment of effective vaccination schedules. Asymmetric repertoire of antibody-secreting cells 619
